These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Systemic diseases affecting the skeletal system]. Hehrmann R; Eliwo-Bamokyaka M Z Gastroenterol Verh; 1986 Apr; 21():27-34. PubMed ID: 2422837 [No Abstract] [Full Text] [Related]
7. Bone disorders in cholestatic liver diseases. Isaia G; Di Stefano M; Roggia C; Ardissone P; Rosina F Forum (Genova); 1998; 8(1):28-38. PubMed ID: 9514992 [TBL] [Abstract][Full Text] [Related]
8. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215 [TBL] [Abstract][Full Text] [Related]
9. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Crippin JS; Jorgensen RA; Dickson ER; Lindor KD Am J Gastroenterol; 1994 Jan; 89(1):47-50. PubMed ID: 8273797 [TBL] [Abstract][Full Text] [Related]
10. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Guañabens N; Parés A; Mariñoso L; Brancós MA; Piera C; Serrano S; Rivera F; Rodés J Am J Gastroenterol; 1990 Oct; 85(10):1356-62. PubMed ID: 2220729 [TBL] [Abstract][Full Text] [Related]
11. [Osteoporosis]. Ziegler R Schweiz Rundsch Med Prax; 1994 Sep; 83(38):1051-5. PubMed ID: 7939067 [TBL] [Abstract][Full Text] [Related]
12. [Serum calcitonin and adrenal steroid serum levels in primary biliary cirrhosis (effect of intravenous calcium)]. Szalay F; Fehér T; Zséli J; Földes J; László B; Holló I Orv Hetil; 1984 Oct; 125(42):2541-4, 2547. PubMed ID: 6387580 [No Abstract] [Full Text] [Related]
13. [Therapy of the chronic destructive, non-purulent cholangitis (primary biliary cirrhosis)]. Brunner G Dtsch Med Wochenschr; 1976 Sep; 101(36):1325-6. PubMed ID: 954585 [No Abstract] [Full Text] [Related]
14. Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study. Benetti A; Crosignani A; Varenna M; Giussani CS; Allocca M; Zuin M; Podda M; Battezzati PM J Clin Gastroenterol; 2008 Mar; 42(3):306-11. PubMed ID: 18223492 [TBL] [Abstract][Full Text] [Related]
15. [Disorders of bone metabolism in gastrointestinal and hepatic diseases]. van Daele PL; Pols HA Ned Tijdschr Geneeskd; 2000 Mar; 144(10):462-7. PubMed ID: 10726154 [TBL] [Abstract][Full Text] [Related]
16. [Replacement therapy in primary biliary cirrhosis]. Beuers U; Gerbes AL Dtsch Med Wochenschr; 1995 Sep; 120(37):1259-60. PubMed ID: 7671787 [No Abstract] [Full Text] [Related]
17. Bone disease and calcium absorption in primary biliary cirrhosis with special reference to vitamin-D therapy. Kehayoglou AK; Holdsworth CD; Agnew JE; Whelton MJ; Sherlock S Lancet; 1968 Apr; 1(7545):715-8. PubMed ID: 4170960 [No Abstract] [Full Text] [Related]
18. Management of osteoporosis in primary biliary cirrhosis. Wolfhagen FH; van Buuren HR; Vleggaar FP; Schalm SW Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):629-41. PubMed ID: 10976019 [TBL] [Abstract][Full Text] [Related]
19. Skeletal renewal and metabolic bone disease. Harris WH; Heaney RP N Engl J Med; 1969 Feb; 280(6):303-11 concl. PubMed ID: 4302928 [No Abstract] [Full Text] [Related]
20. Treatment of osteoporosis with fluoride. Riggs BL; Jowsey J Semin Drug Treat; 1972; 2(1):27-33. PubMed ID: 5048562 [No Abstract] [Full Text] [Related] [Next] [New Search]